Farestos 20 mg Pharmacom Labs

Farestos 20 mg from Pharmacom Labs is a selective estrogen receptor modulator. It was first developed for the treatment of breast and prostate cancer. Today, Pharmacom Labs is widely used by UK bodybuilders and other athletes to reverse the estrogenic side effects of a steroid regimen.

Farestos 20 mg is a product which allows you to restore the production of natural testosterone in a fairly short period of time with a gentle effect on the body. After a simple course of steroids, a one-month course of the inhibitor with a gradual reduction of the dose is sufficient. The duration of recovery therapy after a difficult course is increased up to six weeks.

Structure of Farestos 20 mg

Farestos 20 mg tablet contains:

• Active substance – toremifene citrate 20 mg

Excipients:

• Corn starch, lactose monohydrate, microcrystalline cellulose, sodium carboxymethyl starch, povidone, magnesium stearate, colloidal silicon dioxide.

Packaging video review Farestos 20 mg Pharmacom Labs

 

 

Indications for use of Farestos 20 mg by Pharmacom Labs

PCT in bodybuilding and other strength disciplines is very important if an English athlete uses aromatizing anabolic and androgenic drugs. As a result of excess testosterone on a course of steroids, some of it has time to be metabolized and converted to estrogen.

Taking Farestos 20 mg from Pharmacom Labs allows:

• reduce aromatization and estrogen levels;
• avoid fluid retention and the development of gynecomastia;
• restore natural testosterone production.

Anabolic and androgenic steroids, which act on progesterone receptors, are an indication for the use of the drug on SCT. Progesterone surges can cause side effects similar to those caused by increased estrogen levels. Unlike other aromatase inhibitors such as tamoxifen, Farestos 20 mg acts more selectively and does not bind to progesterone receptors.

Dosage of Farestos 20 mg by Pharmacom Labs

Before you buy and start taking Farestos 20 mg, you should consult your doctor. A specialist will calculate the correct individual dosage, taking into account the complexity of the steroid course and the peculiarities of the athlete’s body. After light anabolic cycles it is sufficient to take 30 mg of toremifene per day, and after two weeks reduce the dosage to 15 mg.

PCT after a heavy course requires daily dosing of 60 mg for a fortnight. In the third and fourth weeks the dose is reduced to 30 mg, in the last two weeks to 15 mg per day.